Table 3.
Management of Secondary Treatment After Recurrence and Visual Function Before Secondary Treatment
Management of Secondary Treatment After Recurrence | |||
---|---|---|---|
Parameters | Number of Patientsn = 18 | ||
Treatment | |||
Resection | 2 (11%) | ||
FSRT | 16 (89%) | ||
FSRT | |||
Dose per fraction (Gy) | 1.8 | ||
Median total dose (Gy) | 54.0 | ||
Range total dose (Gy) | 52.2–54.0 | ||
Median GTV (range) in ccm | 19.8 (10.9–134.3) | ||
Median PTV (range) in ccm | 150.1 (18.8–454.4) | ||
Visual Function Before Secondary Treatment | |||
Baseline | Stable/ Improved | Worsened | |
Double vision | 2 (11%) | 1 (6%) | 1 (6%) |
Visual field restriction | 8 (44%) | 6 (33%) | 2 (11%) |
Visual impairment right eye | 6 (33%) | 0 (0%) | 6 (33%) |
Visual impairment left eye | 5 (28%) | 2 (11%) | 3 (17%) |
FSRT, fractionated stereotactic radiotherapy; GTV, gross tumor volume; PTV, planning target volume.